Clinical Trial Update: Vaccine Study for Surgically Resected Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a vaccine study in patients with surgically resected pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: NewLink Genetics Corporation | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED